Status:
COMPLETED
Assessment of the Rosacea Prevalence in the General Population
Lead Sponsor:
Galderma R&D
Conditions:
Rosacea
Eligibility:
All Genders
18-65 years
Brief Summary
Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.
Detailed Description
Primary objective: Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis
Eligibility Criteria
Inclusion
- Part I
- Inclusion Criteria:
- The following subjects will be included in the study:
- Subjects aged 18 to 65 years old from the general population
- Subjects who are willing to complete the questionnaires
- Part II
- Inclusion Criteria:
- The following subjects will be included in Part II of the study:
- Subjects who screened positive for rosacea during the first part of the study and selected by random method
- Subjects who gave their informed consent to participate in Part II of the study
Exclusion
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT02292797
Start Date
September 1 2013
End Date
February 1 2014
Last Update
November 17 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.